Edition:
United States

GlaxoSmithKline PLC (GSK.F)

GSK.F on Frankfurt Stock Exchange

14.90EUR
15 Dec 2017
Change (% chg)

€-0.05 (-0.37%)
Prev Close
€14.95
Open
€15.00
Day's High
€15.00
Day's Low
€14.89
Volume
13,303
Avg. Vol
60,161
52-wk High
€19.90
52-wk Low
€14.65

Chart for

About

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare... (more)
No analyst recommendations are available for .

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 32.20 16.04
EPS (TTM): -- -- --
ROI: -- 15.06 34.69
ROE: -- 16.55 15.46

BRIEF-Glaxosmithkline Submits Regulatory Application For Single-Dose Tafenoquine For Treatment Of Plasmodium Vivax Malaria

* SUBMITS REGULATORY APPLICATION FOR SINGLE-DOSE TAFENOQUINE FOR TREATMENT OF PLASMODIUM VIVAX MALARIA TO AUSTRALIA'S THERAPEUTIC GOODS ADMINISTRATION​

Dec 14 2017

BRIEF-Glaxosmithkline Posts H1 Consol Profit

* H1 CONSOL NET PROFIT EGP 103.9 MILLION VERSUS LOSS OF EGP 34.6 MILLION YEAR AGO‍​

Dec 14 2017

BRIEF-Egypt's Glaxosmithkline Posts H1 Standalone Profit

* H1 STANDALONE NET PROFIT EGP 101.7 MILLION VERSUS LOSS OF EGP 31.7 MILLION YEAR AGO

Dec 13 2017

BRIEF-Glaxosmithkline Says ‍New Data From Phase III Clinical Study Supports Safety And Efficacy

* ‍NEW DATA FROM A PHASE III CLINICAL STUDY SUPPORTS SAFETY AND EFFICACY OF SHINGRIX IN PREVENTING SHINGLES​

Dec 06 2017

Australian watchdog takes GlaxoSmithKline, Novartis units to court

The Australian Competition and Consumer Commission (ACCC) on Wednesday said it is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products.

Dec 05 2017

PRESS DIGEST- Financial Times - Dec 6

Dec 6 The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.

Dec 05 2017

UPDATE 1-Australian watchdog takes GlaxoSmithKline, Novartis units to court

Dec 6 The Australian Competition and Consumer Commission (ACCC) on Wednesday said it is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products.

Dec 05 2017

Australia competition watchdog takes GlaxoSmithKline, Novartis units to court

Dec 6 The Australian Competition and Consumer Commission (ACCC) on Wednesday said it is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products.

Dec 05 2017

BRIEF-John Wood Group Wins Multi-Million Dollar Contract Supporting Glaxosmithkline In Germany​

* ‍WOOD WINS MULTI-MILLION DOLLAR CONTRACT SUPPORTING GLAXOSMITHKLINE IN GERMANY​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Dec 05 2017

New vaccine, long-acting drug trials buoy hopes in HIV fight

LONDON Researchers announced the launch of two big studies in Africa on Thursday to test a new HIV vaccine and a long-acting injectable drug, fueling hopes for better ways to protect against the virus that causes AIDS.

Nov 30 2017

Earnings vs. Estimates